Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

TKMR RSS Feed
Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tonyeight, nanopatent, stock_MD, KarinCA, [SMART MONEY] , baseball74
Search This Board:
Last Post: 10/21/2014 11:03:57 PM - Followers: 133 - Board type: Free - Posts Today: 41

Tekmira Pharmaceuticals Corporation

 

(TSE:TKM, or US TKMR) 

 

 

http://www.tekmirapharm.com

 

 

 

 

 

Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201

 

As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.

 

Management:   http://www.tekmirapharm.com/Corporate/Management.asp

Pipeline:   http://www.tekmira.com/pipeline/pipeline-products.php 
 

Important Company Highlights: 

SNALP
Tekmira's siRNA delivery technology platform is termed SNALP for "stable nucleic acid-lipid particles". SNALP are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA. Pre-clinical studies have shown them to be effective in delivering the drug to target organs and into cells where the nucleic acid-based drug can carry out its desired effect while minimizing systemic toxicity.

SNALP technology relies on something called the "enhanced permeability and retention effect", which occurs because these nucleic acid-containing particles have a long circulation time in the blood, resulting in increased accumulation at sites of vascular leak such as those found at sites of tumor cell growth, infection or inflammation. Once at the target site, cells take up the SNALP through endocytosis and the nucleic acid payload is delivered inside the cell resulting in unparalleled potency.

 

 

********************************************************************************************

 

Recent News:  

http://tmx.quotemedia.com/news.php?qm_symbol=TKM#page1
http://investor.tekmirapharm.com/releases.cfm
http://finance.yahoo.com/q?s=tkmr&ql=1 

http://www.marketwatch.com/investing/stock/tkmr/news

 ********************************************************************************************

 

Filings: 
http://www.tekmirapharm.com/Investors/Shareholder_Reports.asp

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001447028&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Links of importance for those that trade Canadian stocks:

 Sedar:   http://www.sedar.com/homepage_en.htm

 TMX:.  http://www.tmx.com/

 TMXmoney:   http://www.tmxmoney.com/en/index.html

 CNW Group Newswire:   http://www.cnxmarketlink.com/en/index.cgi

Canadian Insider:    http://canadianinsider.com/coReport/allTransactions.php?ticker=tkm

Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html

 

Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

 
Share Structure:   See filings


Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter: 
http://www.bankofcanada.ca/en/rates/converter.html


 

 

 

 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TKMR
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for TKMR
TKMR News: Current Report Filing (8-k) 10/15/2014 03:29:36 PM
TKMR News: Current Report Filing (8-k) 10/14/2014 06:04:42 AM
TKMR News: Current Report Filing (8-k) 10/09/2014 12:59:49 PM
TKMR News: Current Report Filing (8-k) 10/03/2014 06:05:10 AM
TKMR News: Current Report Filing (8-k) 10/03/2014 06:01:11 AM
PostSubject
#2246  Sticky Note Tekmira Pharmaceuticals Corp. Is More Than Just A kei 08/27/14 04:53:01 PM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#1081  Sticky Note FDA ALLOWS limited USE OF EBOLA DRUG... [SMART MONEY] 08/09/14 11:44:12 PM
#961  Sticky Note For the studious - this is very detailed nanopatent 08/08/14 05:18:35 PM
#4268   IND and Orphan designation could add to TKMR. Echo20 10/21/14 11:03:57 PM
#4267   Yep tomorrow should be fun dmcc2087 10/21/14 10:15:39 PM
#4266   Absolutely BIG NEWS!! willmakeitrain 10/21/14 10:05:13 PM
#4265   Great news tonight, FDA authorized the Company dmcc2087 10/21/14 09:58:58 PM
#4264   Lol willmakeitrain 10/21/14 09:58:55 PM
#4263   So who thinks this will bounce hard? dmcc2087 10/21/14 09:54:51 PM
#4262   You can sell to me at 15 :) short_slayer 10/21/14 09:51:17 PM
#4261   Maybe MMs drive this down a little more.. short_slayer 10/21/14 09:50:27 PM
#4260   No doubt!---talk about saving lives! willmakeitrain 10/21/14 09:42:45 PM
#4259   I don't wear them..and have fun with-that willmakeitrain 10/21/14 09:41:28 PM
#4258   Hope we close up 10% beardown027 10/21/14 09:16:52 PM
#4257   Agreed. beardown027 10/21/14 09:14:58 PM
#4256   After hours: TKMR $18.81* 0.834.62% nanopatent 10/21/14 09:10:16 PM
#4255   Beardown027 Once the new Ebola scanners are ready and Echo20 10/21/14 08:41:09 PM
#4254   -----AVAILABLE BY DECEMBER!!!!---- willmakeitrain 10/21/14 08:39:54 PM
#4253   Honestly? I wouldn't be getting my panties all beachcomber1 10/21/14 08:38:47 PM
#4252   let's get this NEWS stickied!!!!!!!!! willmakeitrain 10/21/14 08:36:41 PM
#4251   VANCOUVER, British Columbia, Oct. 21, 2014 (GLOBE NEWSWIRE) willmakeitrain 10/21/14 08:35:56 PM
#4250   time to run--------->#TKMR willmakeitrain 10/21/14 08:32:18 PM
#4249   Ironic, just talking today about how there needs beardown027 10/21/14 08:23:13 PM
#4248   This is awesome news!! I'm with you, omri 10/21/14 08:22:57 PM
#4247   Here we go, omri! beardown027 10/21/14 08:20:43 PM
#4246   http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107416466 beachcomber1 10/21/14 08:09:52 PM
#4245   post the link! willmakeitrain 10/21/14 08:08:39 PM
#4244   NEWSSSS!! TOMORROW WE RUN!! GLTA omri 10/21/14 08:05:42 PM
#4243   should see a bounce soon 4 days in dmcc2087 10/21/14 07:57:16 PM
#4242   Beardown027 Great. That could get some notoriety. It would be nice Echo20 10/21/14 06:32:52 PM
#4241   Totally agree it could be. However because it's beardown027 10/21/14 03:09:35 PM
#4240   Thanks you too. I have $25s. Yuck. Not beardown027 10/21/14 03:03:47 PM
#4239   Nov. $32.50. Gltu omri 10/21/14 02:54:14 PM
#4238   beardown027 Could that be the Canadian effect of TEKMIRA Echo20 10/21/14 02:51:12 PM
#4237   Last year it was Nov 13. This year beardown027 10/21/14 02:48:46 PM
#4236   When are earnings? Tia omri 10/21/14 02:39:44 PM
#4235   That's coupled with a cocktail of other drugs beardown027 10/21/14 02:21:16 PM
#4234   Unofficially TKMR is successful in 6 patients out Echo20 10/21/14 02:06:29 PM
#4233   Fenig The new target is as close to exposure Echo20 10/21/14 01:53:31 PM
#4232   ***VERY SOLID***19.00 first-resistance range--50ma@20.89 follows..- willmakeitrain 10/21/14 11:24:08 AM
#4231   ----THATS GOOD NEWS-!!! willmakeitrain 10/21/14 09:27:19 AM
#4230   "Tekmira’s TKM-Ebola has been administered to seven patients, Fenrig 10/21/14 08:59:08 AM
#4229   Meet the Competition. Tablet form. Echo20 10/21/14 08:55:43 AM
#4228   great trader if you have the stomach stock_MD 10/21/14 01:18:04 AM
#4227   A new twist : Echo20 10/20/14 11:16:32 PM
#4226   I'm in the same boat. Hope we get beardown027 10/20/14 10:55:23 PM
#4225   OMRI Maybe TKMR will get over the shock of Echo20 10/20/14 09:50:55 PM
#4224   What should we expect tomorrow? I hope we omri 10/20/14 09:00:00 PM
#4223   The third patient was released from Emory Hospital. Echo20 10/20/14 08:00:09 PM
#4222   I hope so dmcc2087 10/20/14 07:56:35 PM
#4221   Looking for a safe re-entry.Everything Ebola rated got cjmeyer 10/20/14 07:33:42 PM
#4220   So there is no travel ban? how smart Splinter_Cell 10/20/14 05:18:00 PM
#4219   Several people have been released that do not Echo20 10/20/14 05:13:30 PM
PostSubject